A micronutrient status evaluation platform for nutritional therapy support

用于营养治疗支持的微量营养素状态评估平台

• 批准号: 10046457
• 金额: $ 6.37万
• 依托单位: PERSOMIC LTD
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10046457
• 关键词: micronutrient; status; evaluation; platform; nutritional

Micronutrient deficiency is widespread in the UK, and contributes to disease. Seventy to ninety percent of adults in Europe are vitamin D deficient or insufficient, with associated poor bone health, high blood pressure, diabetes, prostate cancer, and more. In the UK, every year there are fifty thousand new cases of prostate cancer, costing the nation EUR €117M per annum. Yet, the relationship between vitamin D and prostate cancer is just one of hundreds of micronutrient-disease associations. Simply taking a multivitamin is not the ideal solution because each of us has a different requirement based on genetics and environment. Persomic tells you which micronutrients to take to meet your individual needs by connecting dots between history, symptoms and lab results. We use big data technology to perform a networked analysis of biomarkers, revealing options for nutritional therapy to manage health and disease, that might otherwise be missed.

营养素缺乏症在英国很普遍，并导致疾病。欧洲70%至90%的成年人缺乏维生素D或维生素D不足，并伴有骨骼健康不良、高血压、糖尿病、前列腺癌等。在英国，每年有5万例新的前列腺癌病例，每年花费国家1.17亿欧元。然而，维生素D和前列腺癌之间的关系只是数百种微量营养素疾病关联之一。简单地服用复合维生素并不是理想的解决方案，因为我们每个人都有基于遗传和环境的不同需求。营养学通过将病史、症状和实验室结果联系起来，告诉你应该服用哪些微量营养素来满足你的个人需求。我们使用大数据技术对生物标志物进行网络分析，揭示营养疗法的选择，以管理健康和疾病，否则可能会错过。